Our study highlights wild‐type IDH1 as a key enzyme required for PCa cell metabolism by causing an unusual metabolic adaptation to support mitochondrial respiration and uncovering a possible new therapeutic target for PCa (Fig. 6). The gene discussed is IDH1; the disease is posterior cortical atrophy.